Skip to main content
Log in

Plaquestabilisierung und Endothelschutz durch Cholesterin-synthesehemmer

  • Bundesverband Niedergelassener Kardiologen
  • Die persönliche Meinung
  • Published:
Herz Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Anderson TJ, Meredith IT, Yeung AC, et al. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med 1995;23:488–93.

    Article  Google Scholar 

  2. Andrews T.C., Raby K., Barry J., Naimi C.L., Allred E., Ganz P., Selwyn A.P.: Effect of Cholesterol Reduction on Myocardial Ischemia in Patients with Coronary Disease. Circulation 95 (1997), 324–327

    PubMed  CAS  Google Scholar 

  3. van Boven A. J., Jukema J. W., Zwindermann A. H., Crijns H. J. G. M., Lie K. J., Bruschke A. V. G.: Reduction of Transient Myocardial Ischemia with Pravastatin in Addition to the Conventional Treatment in Patients with Angina Pectoris. Circulation 94 (1996), 1503–1505

    PubMed  Google Scholar 

  4. Brown B. G., Zhao X-Q, Sacco D. E., Albers J. J.: Lipid Lowering and Plaque Regression. Circulation 87 (1993), 1781–1791

    PubMed  CAS  Google Scholar 

  5. Cannon R. O.: Does Coronary Endothelial Dysfunction Cause Myocardial Ischemia in the Absence of Obstructive coronary Artery Disease? Circulation 96 (1997), 3251–3254

    PubMed  Google Scholar 

  6. Celermajer D. S.: Endothelial Dysfunction: Does it Matter? Is it Reversible? JACC 30 (1997), 325–333

    PubMed  CAS  Google Scholar 

  7. Clarkson P., Celermajor D. S., Powe A. J., Donald A. E., Henry R. M. A., Deanfieldn, J. E.: Endothelium-Dependent Dilatation Is Impaired in Young Healthy Subjects with a Family History of Premature Coronary Disease. Circulation 96 (1997), 3378–3383

    PubMed  CAS  Google Scholar 

  8. Egashira K., Hirooka Y., Kai H., Sugimachi M., Suzuki S., Takeshita A.: Reduction in Serum Cholesterol With Pravastatin Improves Endothelium-Dependent Coronary Vasomotion in Patients With Hypercholesterolemia. Circulation 89 (1994) 2519–2524

    PubMed  CAS  Google Scholar 

  9. Fuster V., Poon, M., Willerson J. T.: Learning from the Transgenic Mouse. Circulation 97 (1997), 16–18

    Google Scholar 

  10. Hasdai D., Gibbons R. J., Holmes D. R., Higano S. T., Lerman A.: Coronary Endothelial Dysfunction in Humans Is Associated with Myocardial Perfusion Defects. Circulation 96 (1997), 3390–3395

    PubMed  CAS  Google Scholar 

  11. Kinlay S., Selwyn A. P., Delagrange D., Creager M. A., Libby P., Ganz P.: Biological mechanisms for the clinical success of lipid-lowering in coronary artery diesease and the use of surrogate end-points. Curr Opin Lipidol 7 (1996), 389–397.

    Article  PubMed  CAS  Google Scholar 

  12. Lacoste L., Lam J. Y. T., Hung, J., Letchacovski G., Solymoss C. B., Walters D.: Hyperlipidemia and Coronary Disease. Correction of the Increased Thrombogenic Potential with Cholesterol Reduction. Circulation 92 (1995), 3172–3177

    PubMed  CAS  Google Scholar 

  13. Laufs U., La Fata V., Liao J. K.: Inhibition of 3-Hydroxy-3-methylglutariy (HMG)-CoA Reductase Blocks Hypoxia-mediated Down-regulation of Endothelial Nitric Oxide Synthase. JBC 272 (1997), 31725–31729

    Article  CAS  Google Scholar 

  14. Laufs U., La Fata V., Plutzky J., Liao J. K.: Upregulation of Endothelial Nitric Oxide Synthase by HMG-CoA Reductase Inhibitors. Circulation 97 (1998), 1129–1135

    PubMed  CAS  Google Scholar 

  15. Libby P.: Molecular basis of the acute coronary syndrome. Circulation 91 (1995), 2844–2850

    PubMed  CAS  Google Scholar 

  16. Müller-Wieland D., Kotzka J., Krone W.: Stabilization of atherosclerotic plaque during lipid lowering. Curr Opin Lipidol 8 (1997), 348–353

    Article  PubMed  Google Scholar 

  17. Müller-Wieland D., Faust M., Krone W.: Cholesterinsynthesehemmer — Klinische Studien zur Senkung des koronaren Risikos und Plaque-Stabilisierung. Internist 39 (1998) 934–942

    Article  PubMed  Google Scholar 

  18. Münzel T., Heitzer T., Harrison D. G.: The Physiology and Pathophysiology of the Nitric Oxide/Superoxide System. Herz 22 (1997), 157–172.

    Article  Google Scholar 

  19. O’Driscoll G., Green D., Taylor R. R.: Simvastatin, an HMG-Coenzyme A Reductase Inhibitor, Improves Endothelial Function within 1 Month. Circulation 95 (1997) 1126–1131

    PubMed  Google Scholar 

  20. Rosenson R. S., Tangney C. C.: Antiatherothrombotic Properties of Statins. JAMA 27 (1998), 1643–1650

    Article  Google Scholar 

  21. Sampietro T., Tuoni, M., Ferdeghini, M., Ciardi A., Marraccini P., Pronterea C., Sassi G., Taddei M., Bionda A.: Plasma Cholesterol Regulates Soluble Cell Adhesion Molecule Expression in Familial Hypercholesterolemia. Circulation 96 (1997), 1381–1385

    PubMed  CAS  Google Scholar 

  22. Tamai O., Matsuoka H., Itabe H., Wada Y., Kohno K., Imaizumi T.: Single LDL Apheresis Improves Endothelium-Dependent Vasodilatation in Hypercholesterolemic Human. Circulation 95 (1997), 76–82.

    PubMed  CAS  Google Scholar 

  23. Treasure C. B., Klein J. L., Weintraub W. S., Talley J. D., Stillabower M. E., Kosinski A. S., Zhang J., Boccuzzi S. J., Cedarholm J. C., Alexander R. W.: Beneficial Effects of Cholesterol-Lowering Therapy on the Coronary Endothelium in Patients with Coronary Artery Disease. N Engl J Med 332 (1995), 481–487

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dirk Müller-Wieland.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Müller-Wieland, D., Faust, M., Kotzka, J. et al. Plaquestabilisierung und Endothelschutz durch Cholesterin-synthesehemmer. Herz 24, 254–257 (1999). https://doi.org/10.1007/BF03044972

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03044972

Navigation